Menopause Mastery

21. The importance of Estriol (E3) and an introduction to receptor sites.

1 Quiz

Quiz 21: Importance of Estriol

22. Prescribing Bi-est: Understanding the E3/E2 ratio. “mgeeq”: the oh-so-important math on potencies and ratios.

1 Quiz

Quiz 22: Potencies and Ratios

23. Calculating Bi-Est potency

1 Quiz

Quiz 23: Calculating Potencies and Ratios

24. All about bases

1 Quiz

25. Individualization. Dose Determination by titration. Receptor site sensitivity and dormancy.

1 Quiz

Quiz 25: Sensitivity and Dormancy

26. Aiming for optimum: balancing drops, concentrations and ratios.

1 Quiz

Quiz 26: Optimum Doses

27. Window of Opportunity: Cardiovascular Risk Considerations

And now we're on to Progesterone!

28. Treat early on!

1 Quiz

Quiz 27: Treating Early

29. The effect on Thyroid, Bone, Sleep and Brain

1 Quiz

Quiz 28: The Effects

30. Breast Cancer risk, SHBG issues.

1 Quiz

Quiz 29: Progesterone Problems

31. Progesterone Poignancies. Transdermal dosage limits. Dermal Fatigue. TVUS.

1 Quiz

Quiz 30: Progesterone and Optimal Dosing

32. Excessive Progesterone Dosages: receptor sites. Unusual Symptoms

1 Quiz

Quiz 31: Unusual Symptoms

33. Common Starting Dosages

1 Quiz

Quiz 32: Starting Dosages

Progesterone. Prescribing and applying Bi-Est and Progesterone: Prescription

34. Writing Your First Prescription. Four Distinct Dosing Schedules in the Dose Determination Process.

1 Quiz

Quiz 33: First Prescription

35. Topical hormone application: the how and the when for Bi-est and progesterone.

1 Quiz

Quiz 34: Topical Hormone Applications

36. Topical hormone application: Absorption, dermal fatigue, transmucosal and transmission

1 Quiz

Quiz 35: More on Application

Getting to right-dose

37. Some important factors

1 Quiz

Quiz 36: Important Factors

38. Optimal dose ranges

1 Quiz

Quiz 37: Ranges

39. Variations in Total Potent Estrogens

1 Quiz

Quiz 38: Variations

40. Supra-physiologic dosages… watch out!

1 Quiz

Quiz 39: Supraphysiologic Dosages

2 of 5

Quiz 21: Importance of Estriol

Menopause Mastery 21. The importance of Estriol (E3) and an introduction to receptor sites. Quiz 21: Importance of Estriol

NOTE: select ALL right answers! If more than one answer sounds correct to you, select them both. If three sound correct… yep, select all three!

Time limit: 0

Quiz Summary

0 of 15 questions completed

Questions:

Information

You have already completed this quiz. You cannot start it again.

Quiz is loading…

You must sign in or sign up to take this quiz.

You must first complete the following:

Results

Quiz complete. Results are being recorded.

Results

0 of 15 questions answered correctly

Your Time:

Time has elapsed.

You have reached 0 of 0 point(s), (0)

Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)

Average Score
Your Score

Categories

Not categorized 0%

Your grade: F
Your grade: D
Your grade: D+
Your grade: C-
Your grade: C
Your grade: C+
Your grade: B-
Your grade: B
Your grade: B+
Your grade: A-
Your grade: A
Your grade: A+

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

Current
Review
Answered
Correct
Incorrect

Question 1 of 15

1. Question
Which of the following statements about estrogen biochemistry is FALSE?
- 2 hydroxy estrone (2OHE1) and 16 alphahydroxyestrone (16aOHE1) are the two principal metabolites of E2
- 2 hydroxy estrone (2OHE1) and 16 alphahydroxyestrone (16aOHE1) are the two principal metabolites of E1
- E3 is the principal metabolite of 16aOHE1
Correct

Incorrect
Question 2 of 15

2. Question
Which of the following statements about estrogen biochemistry is FALSE?
- The three principal hormonally active estrogens are estradiol (E2), estrone (E1) and estriol E3)
- E2 is more potent than E3 which is more potent than E1
- E2 is more potent than E1 which is more potent than E3
Correct

Incorrect
Question 3 of 15

3. Question
What statements are TRUE of estrogen metabolites? Select all that apply.
- A healthy liver will methylate estrogen metabolites 2OHE1 & 16aOHE1 for excretion
- A healthy liver will methylate estrogen metabolites 2OHE1 & 4 hydroxyestrone (4OHE1) for excretion
- 4OHE1 is the least favorable of the estrogen metabolites
Correct

Incorrect
Question 4 of 15

4. Question
Which of the following statements about estrogen potency is correct?
- E1 is 40% as potent as E2
- E2 is 80% as potent as E1
- E1 is 80% as potent as E2
Correct

Incorrect
Question 5 of 15

5. Question
Which of the following statements about estrogen potency is correct?
- E3 is 13% as potent as E2
- E3 is 25% as potent as E2
- E3 is 50% as potent as E2
Correct

Incorrect
Question 6 of 15

6. Question
Which of the following statements about estrogen prevalency is TRUE?
- E1 is over twice as prevalent E2 in a 24 hour urine sample of a young healthy woman
- E3 is about 6 times as prevalent E2 in a 24 hour urine sample of a young healthy woman
- E3 is 1 – 2 times as prevelant as the sum of E2 + E1 in a 24 hour urine sample of a young healthy woman
- All of the above
- None of the above
Correct

Incorrect
Question 7 of 15

7. Question
Which of the following statements about estrogen math are TRUE? Select all that apply.
- We refer to the sum of E2 + E1 in a 24 hour urine sample of a young healthy woman as "the total potent estrogens" (TPE's)
- E3/TPE's is referred to as the "Estrogen Fraction" (EF) or the "Estrogen Prevalence forulation" (EPF)
- E3/TPE's is referred to as the "Estrogen Quotient" (EQ) or the "Estrogen Ratio" (ER)
Correct

Incorrect
Question 8 of 15

8. Question
Which of the following statements about estrogen math are TRUE? Select all that apply.
- We prefer to have the EQ to be >1
- We prefer to have the EQ to be between 1 – 4
- We prefer to have the EQ to be <1
Correct

Incorrect
Question 9 of 15

9. Question
Which statment about estrogen receptor sites is TRUE?
- Estrogen receptor site alpha (ERa) engagement encourages the proliferation of breast glandular cells in preparation for possible pregnancy and the beginning of preparation for lactation
- Estrogen receptor site beta (ERb) engagement encourages the proliferation of breast glandular cells in preparation for possible pregnancy and the beginning of preparation for lactation
- Estrogen receptor site beta (ERb) is prominent during the first half of the cycle
Correct

Incorrect
Question 10 of 15

10. Question
Which statment about estrogen receptor sites is FALSE?
- Estrogen receptor site alpha (ERa) engagement encourages the deproliferation via apoptosis of breast glandular cells should there be no fertilization
- Estrogen receptor site beta (ERb) engagement encourages the deproliferation via apoptosis of breast glandular cells should there be no fertilization
- Deproliferation of breast glandular cells takes place in the second half of the cycle
Correct

Incorrect
Question 11 of 15

11. Question
Select all that apply. Breast glandular proliferation involves:
- Increase in breast fullness as the cycle progresses
- Cell proliferation via mitosis
- Cell expansion via increasing potentiation
Correct

Incorrect
Question 12 of 15

12. Question
Which of the following statements about estrogen receptor sites are true?
- ERa enhances proliferation and is stimulated primarily by E2
- ERb is deproliferative and is stimulated primarily by E3
- Highest priorities in treating women in menopause: do not cause mitosis or breast glandular cell proliferation
- All of the above
- None of the above
Correct

Incorrect
Question 13 of 15

13. Question
Estrogen receptor sites:
- Should contain adequate E3 to ultimately result in an EQ >1
- Should be created in a way that "copies nature" producing a 24 hour urine profile that aligns with that of a young healthy woman
- Should contain both E3 and E2 with, most commonly, a marked prominence of E3
Correct

Incorrect
Question 14 of 15

14. Question
Estrogen treatment formulations for women in menopause:
- Estrone is needed as well in the formulation to copy nature
- Estrone is not needed in the formulation to copy nature
- Optimal formulation for treating a woman in menopause is Bi-est
Correct

Incorrect
Question 15 of 15

15. Question
Which of the following statements about estrogen treatment formulations for women in menopause is TRUE?
- Estradiol is not needed
- Estriol alone is sufficient
- You will not be able to replicate nature's estrogen balance without including both E3 + E2
Correct

Incorrect

Login

Accessing this course requires a login. Please enter your credentials below!

Username or Email Address

Password

Remember Me

Lost Your Password?

iobim-color

Register

Don't have an account? Register one!

Register an Account

Username

Email

Registration confirmation will be emailed to you.